Increased expression of ABCB1 (P‐gp), a drug efflux pump confers the cancer cells' resistance to doxorubicin and taxol via decreased intracellular drug concentration.[59] Another m6A writer, WTAP, produces cisplatin resistance in NK/T cell lymphoma (NKTCL) via m6A‐mediated upregulation of DUSP6. Here, ABCB1 is linked to extranodal nasal NK/T cell lymphoma.